Advancing ALS research with speech acoustics
YourHealthMatters
“Her speech acoustics research is helping to advance early detection and monitoring of bulbar signs in Amyotrophic Lateral Sclerosis (ALS), a progressive and debilitating neurodegenerative disease.”
TAGS: Amyotrophic Lateral Sclerosis (ALS), clinical trial, Canadian research, Sunnybrook Research Institute
‘This is the future of medicine’: Centre for Commercialization of Regenerative Medicine CEO Michael May on bringing Canada’s life science discoveries to market
Toronto Star
“Cell and gene therapies promise incredible advances in cancer and heart disease treatment.”
TAGS: cell and gene therapies, innovative research, Ottawa Hospital Research Institute, University Health Network
Looking for a definitive cure for HIV
Queen’s Gazette
“Infectious diseases clinician and researcher Santiago Perez is advancing work on HIV immunology and the ongoing search for a cure.”
TAGS: human immunodeficiency virus (HIV), antiretroviral drugs, social determinants of health, Queen’s University
USask researchers awarded NSERC funding for future innovation in science, health and engineering
University of Saskatchewan
“University of Saskatchewan (USask) researchers in diverse disciplines were awarded over $7 million in federal government grant funding.”
TAGS: NSERC Discovery Grant, Canadian research, University of Saskatchewan
Women have a higher chance of developing long COVID than men, study finds – CTV News
CTV News
“New research has found that women are ‘significantly’ more likely than men … conducted by researchers from the Johnson & Johnson Office of the Chief Medical Officer Health of Women Team, found the odds of females …”
TAGS: long COVID, sex-disaggregated research, immune system function, Johnson & Johnson
Pfizer says tweaked COVID-19 vaccines boost Omicron protection – The Globe and Mail
The Globe and Mail
“Pfizer says tweaked COVID-19 shots boost omicron protection. … Make more informed decisions with Canada’s leading source of business and …”
TAGS: COVID-19, vaccine booster, Omicron-fighting antibodies, Pfizer